H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway.

Eberhardt M, Dux M, Namer B, Miljkovic J, Cordasic N, Will C, Kichko TI, de la Roche J, Fischer M, Suárez SA, Bikiel D, Dorsch K, Leffler A, Babes A, Lampert A, Lennerz JK, Jacobi J, Martí MA, Doctorovich F, Högestätt ED, Zygmunt PM, Ivanovic-Burmazovic I, Messlinger K, Reeh P, Filipovic MR. · 2014

Read H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway. by Eberhardt M, Dux M, Namer B, Miljkovic J, Cordasic N, Will C, Kichko TI, de la Roche J, Fischer M, Suárez SA, Bikiel D, Dorsch K, Leffler A, Babes A, Lampert A, Lennerz JK, Jacobi J, Martí MA, Doctorovich F, Högestätt ED, Zygmunt PM, Ivanovic-Burmazovic I, Messlinger K, Reeh P, Filipovic MR. (2014) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4104458.txt.

Introduction

Mirjam Eberhardt, Peter Reeh, Milos R. Filipovic, and a large team traced how two gas signals, hydrogen sulfide and nitric oxide, jointly relax blood vessels. Their study appeared in Nature Communications in 2014. Their meeting product, nitroxyl, helps the heart but its route to releasing a vessel-widening peptide was unknown.

The gases are produced next to a sensory channel called TRPA1 in nerve endings around vessels. Nitroxyl switches that channel on by forming bonds in the channel, letting calcium flood in for a sustained period. The nerve then releases CGRP, a peptide that widens vessels locally and across the body. Most widening from hydrogen sulfide depended on this chain. The authors call the pathway an essential element of vascular tone control.

Catalog record

CREATOREberhardt M, Dux M, Namer B, Miljkovic J, Cordasic N, Will C, Kichko TI, de la Roche J, Fischer M, Suárez SA, Bikiel D, Dorsch K, Leffler A, Babes A, Lampert A, Lennerz JK, Jacobi J, Martí MA, Doctorovich F, Högestätt ED, Zygmunt PM, Ivanovic-Burmazovic I, Messlinger K, Reeh P, Filipovic MR.
YEAR2014
COLLECTIONPAPERS
FORMATTXT
FILE SIZE93 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4104458

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO–TRPA1–CGRP signalling pathway By Mirjam Eberhardt, Maria Dux, Barbara Namer, Jan Miljkovic, Nada Cordasic, Christine Will, Tatjana I Kichko, Jeanne de la Roche, Michael Fischer, Sebastián A Suárez, Damian Bikiel, Karola Dorsch Published in: Nature Communications DOI: 10.1038/ncomms5381 ABSTRACT Abstract Nitroxyl (HNO) is a redox sibling of nitric oxide (NO) that targets distinct signalling pathways with pharmacological endpoints of high significance in the treatment of heart failure. Beneficial HNO effects depend, in part, on its ability to release calcitonin gene-related peptide (CGRP) through an unidentified mechanism. Here we propose that HNO is generated as a result of the reaction of the two gasotransmitters NO and H2S. We show that H2S and NO production colocalizes with transient receptor potential channel A1 (TRPA1), and that HNO activates the sensory chemoreceptor channel TRPA1 via formation of amino-terminal disulphide bonds, which results in sustained calcium influx. As a consequence, CGRP is released, which induces local and systemic vasodilation. H2S-evoked vasodilatatory effects largely depend on NO production and activation of HNO–TRPA1–CGRP pathway. We propose that this neuroendocrine HNO–TRPA1–CGRP signalling pathway constitutes an essential element for the control of vascular tone throughout the cardiovascular system. Nitroxyl, HNO, is the one-electron-reduced sibling of nitric oxide (NO) but follows an entirely separate signalling pathway1,2. HNO exerts systemic cardiovascular effects by releasing calcitonin gene-related peptide (CGRP) that combines general vasodilation with positive inotropic and lusitropic actions3,4. HNO donors, thus, provide a great promise for the treatment of heart failure, avoiding the problem of nitrate tolerance4,5,6. However, biochemical pathway(s) for HNO generation as well as the physiological mechanism of its CGRP releasing ability are still unknown, whereas abundant CGRP stores do exist inside ubiquitous sensory nerve fibres7,8,9. In this study, we aimed at understanding the actual biochemical pathway for HNO-induced CGRP release and at finding the actual source of HNO in vivo. Recently, a new gaseous signalling molecule emerged, hydrogen sulphide (H2S), with physiological endpoints similar to that of NO10,11,12,13. Some studies even suggested that the effects of H2S and NO are mutually interdependent13,14,15,16. Elegant work on vascular endothelium and smooth muscle recently proposed a parallel formation of NO and H2S, the former entering the guanylyl cyclase pathway, the latter inhibiting phosphodiesterase 5, together thus stabilizing the level of vasorelaxant cyclic GMP14. A direct reaction of NO with thiols is too slow to be of physiological relevance17,18, whereas a direct interaction between NO and H2S has not yet been studied. We hypothesized, however, that the two gasotransmitters could enter a redox reaction with each other, which results in HNO formation—a potential way to intracellular HNO generation, if the H2S and NO producing enzymes were co-expressed. Knowing that the primary targets for HNO are thiols1,2 and the reason for its cardioprotective effect is CGRP release3,4, we hypothesized that HNO acts as an endogenous agonist of transient receptor potential channel A1 (TRPA1), a potential target for H2S (ref. 19) that is expressed in sensory nerve fibres and activated by numerous endogenous metabolites and environmental irritants20,21,22 through covalent modification of particular cysteine residues23,24, leading to para- and/or endocrine CGRP release and to local or general vasodilation, respectively. RESULTS HNO activates TRPA1 in cells and sensory neurons The effects of HNO on Chinese hamster ovary cells stably expressing mTRPA1 were examined by whole-cell voltage clamp. Angeli’s salt (AS) was used as a donor of HNO (Fig. 1). AS decomposes in neutral buffer to give equimolar amounts of nitrite and HNO with a half-life of about 5 min at 37 °C (ref. 25). In addition, HNO dimerizes rapidly (8 × 106 M−1 s−1) (ref. 25) with elimination of water to give inert N2O. Considering the inherent delays in the various experimental set-ups, this implies that the actual concentration of HNO in physiological buffer at the time of measurement was lower (less than half) than that of AS initially dissolved and explains a relatively high dose of AS required to induce an effect. Sixty-second exposures to (initially) 400 μM AS-evoked large sustained inward currents, which could be repeatedly blocked by the TRPA1 channel antagonist HC030031 (Fig. 1b). Control treatment with decomposed AS showed no effect (Supplementary Fig. 1). Measuring ramp currents (−100 to +100 mV in 500 ms), we observed that AS induced an outwardly rectifying current–voltage relationship (Fig. 1b), while decomposed AS was ineffective. [Figure: HNO released by AS activates TRPA1 channels.(a) Treatment with AS (300 μM) but not DEA NONOate (100 μM) increased fluorescence in sensory neurons (DRG) incubated with CuBOT1, a fluorescent dye for nitroxyl detection (analysis of variance following honestly significant difference post hoc test P<0.001; P=0.97, respectively; n=200 per group; scale bar, 40 μm). (b) AS (400 μM, 60 s) evoked inward currents in Chinese hamster ovary cells (n=7) expressing mTRPA1, which could be repeatedly blocked by HC030031 (50 μM, 10 s). Inset: Ramp currents through TRPA1 before (control, black) and during application of either decomposed AS (grey) or 400 μM AS (red). (c) Ca2+ influx (mean±s.e.m.) in DRG neurons of C57Bl/6 mice treated with AS (300 μM, 45 s), AITC (100 μM, 20 s) and capsaicin (0.3 μM, 10 s at 4-min intervals) and corresponding representative pseudocolor images (scale bar, 80 μm). (d) AS effects are abolished by application of HC030031 (50 μM) or decomposed AS and absent in TRPA1−/− mice. DEA NONOate (100 μM, 45 s) caused no effect. Data represent mean±s.e.m., n=300 DRG neurons for each group.] To confirm the observed effects in native sensory neurons, Ca2+ influx was measured in cultured, Fura-2-stained dorsal root ganglion (DRG) neurons of wild-type and TRPA1−/− mice. Forty-five-second exposures to AS caused an increase in intracellular Ca2+ in 28 % of wild-type cells (Fig. 1c). The correlation of the cells responding to AS with responses to the prototypic TRPA1 agonist allyl isothiocyanate (AITC 100 μM, r=0.625) strongly implied the involvement of TRPA1. This was supported by a complete block of AS-evoked Ca2+ increase under HC030031 (Fig. 1d). Wash-out of HC030031 caused an immediate recovery of the previously suppressed AS response, similar to the repeated inhibition and recovery observed in patch clamp experiments (Fig. 1b), suggesting that the activating modifications induced by HNO treatment were sustained. In cells prepared from TRPA1−/− mice, AS, like AITC, had no effect (Fig. 1d), proving that TRPA1 was the receptor channel activated by HNO. In wild-type mice, there was no effect of decomposed AS (Fig. 1d) or of AS applied in Ca2+-free external solution excluding intracellular store depletion (Fig. 1b). The use of a pure NO donor (DEA NONOate) at doses similar to HNO had no effect on intracellular Ca2+ (Fig. 1d). However, high concentrations of NO did induce slow Ca2+ entry, indicative of non-physiological formation of high levels of N2O3 acting as an S-nitrosating agent17 (Supplementary Fig. 2a). In fact, the use of a direct S-nitrosating agent, SNAP, induced reversible Ca2+ influx (at concentrations >1 mM), with the effect being quickly abolished when SNAP was removed (Supplementary Fig. 2b), clearly distinguishing it from sustained Ca2+ influx observed with AS. HNO-induced disulphide formation on TRPA1 hTRPA1 is rich in cysteine residues and C621, C641 and C665 of the N terminus are responsible for electrophilic activation23. To test whether these specific cysteine residues play a role, experiments

Read the complete text